EMAIL: [email protected]
PHONE: 720.213.5963

Laura Drotleff

Laura has specialized in agricultural journalism for the past 20 years. Most recently she served as the editor of a B2B publication and multimedia properties focused on productivity, efficiency and profitability in commercial greenhouse cultivation. She has reported on multiple aspects of specialty crops including floriculture, fruit, vegetables, citrus and cannabis. She also has served extensively on various horticulture industry association boards. Laura is a Michigan State University graduate and is based in Cleveland, Ohio.

FDA submits CBD enforcement policy draft guidance to White House

Published July 23, 2020 | By Laura Drotleff

Federal food and drug officials submitted a CBD enforcement policy document for approval on Wednesday, Hemp Industry Daily has learned.

Federal scientists unveil program to improve hemp, marijuana lab testing accuracy

Published July 23, 2020

A federal science agency launched a program on Tuesday, aimed at helping laboratories accurately measure key chemical compounds in hemp and marijuana products including oils, edibles, tinctures and balms.

FDA’s new guidance on cannabis drug development won’t define path for CBD products, legal experts say

Published July 22, 2020 | By Laura Drotleff

Federal food and drug officials dropped draft guidance for clinical research related to cannabis and cannabis-derived products.

FDA issues guidance for clinical research and development on drugs containing cannabis and derived products

Published July 22, 2020 | By Laura Drotleff

Federal food and drug officials dropped draft guidance for clinical research related to developing cannabis and cannabis-derived drug products.

Charlotte’s Web unveils 76-acre farm art installation in effort to encourage consumers to fight for CBD access

Published July 21, 2020 | By Hemp Industry Daily staff

Colorado hemp producer and CBD maker Charlotte’s Web on Tuesday revealed the latest farm art installation in a campaign to promote hemp for consumer health. Charlotte’s Web unveiled part three of its “Trust The Earth” campaign, a 76-acre farm art installation in McPherson, Kansas, as part of an effort launched in October 2019 to break […]

Fight for control over GenCanna heading to court as company emerges from bankruptcy

Published July 20, 2020

Control over GenCanna, a Kentucky hemp and CBD company that had filed for Chapter 11 bankruptcy in February is now being disputed in a 6th circuit bankruptcy appellate court.

Hemp representative appointed to serve on USDA agriculture policy committee

Published July 20, 2020

Federal agriculture officials named a lone representative of the hemp industry to a committee advising the U.S. Department of Agriculture and Office of the U.S. Trade Representative to advise on trade policy.

Vertical Wellness, GenCanna expand partnership with new biomass tolling, drying deal

Published July 17, 2020

Two large-scale Kentucky hemp companies have expanded their strategic alliance by adding a toll processing and drying technology swap to the deal.

USDA approves hemp production plans for Minnesota, Puerto Rico, Tennessee

Published July 17, 2020 | By Laura Drotleff

Federal agriculture officials with the U.S. Department of Agriculture signed off on hemp production plans for two states and a U.S. territory this week.

Canadian CBD maker appoints former Clorox executive as product development lead

Published July 15, 2020

Neptune Wellness Solutions, a Laval, Quebec-based CBD extractor and manufacturer, has named Eric Gharakhanian as the director of product development for its Health & Wellness Innovations division.

Mississippi directs hemp growers to apply for USDA program, passing on state program

Published July 14, 2020

One of the last hemp holdout states, Mississippi, has directed farmers interested in growing the crop to apply for an individual producer license through the U.S. Department of Agriculture.

Neptune Wellness Solutions to sell $12 million in shares for operating capital

Published July 13, 2020

Neptune Wellness Solutions has entered into definitive agreements with healthcare-focused institutional investors, selling off more than 4.7 million common shares at an offering of U.S. $2.65 per share to raise USD $12.65 million.